M&A Deal Summary |
|
|---|---|
| Date | 2022-12-08 |
| Target | Altamedics |
| Sector | Distribution |
| Buyer(s) | Abiogen Pharma |
| Deal Type | Add-on Acquisition |
SEARCH BY
Abiogen Pharma research and development, manufacturing of pharmaceuticals with its own brand or under third-party contracts, and marketing of own and licensed drugs. Abiogen Pharma was founded in 1997 and is based in Pisa, Italy.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Distribution M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 2 |
| Country: Germany M&A | 1 of 1 |
| Year: 2022 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-05-29 |
EffRx
Freienbach, Switzerland EffRx develops and commercializes drugs, targeted in particular to musculoskeletal and rare diseases. The company's product range includes buffered soluble alendronate, a key agent from the class of bisphosphonates used in the treatment of osteoporosis. It licenses and distributes this drug under license agreements in 29 European and non-European countries. EffRx was founded in 2010 and is based in Freienbach, Switzerland. |
Buy | - |
